Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study

Published 2020 View Full Article

Authors

Keywords

ARCHES, Enzalutamide, Prostate cancer, Metastatic hormone-sensitive, Patient-reported outcomes, Pain

Journal

EUROPEAN UROLOGY

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2020-04-24

DOI

10.1016/j.eururo.2020.03.019

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started